Anti-arrhythmic drugs.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000777:Anesthetics / Q000009:adverse effects; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000145:classification / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000209:etiology; D004206:Disopyramide / Q000627:therapeutic use; D004285:Dogs; D006801:Humans; D007431:Intraoperative Complications; D008012:Lidocaine / Q000627:therapeutic use; D008801:Mexiletine / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D013390:Succinylcholine / Q000009:adverse effects
D000319:Adrenergic beta-Antagonists; D000777:Anesthetics; D000889:Anti-Arrhythmia Agents; D008801:Mexiletine; D010672:Phenytoin; D008012:Lidocaine; D004206:Disopyramide; D013390:Succinylcholine; D011342:Procainamide